Top compounds associated with response to USP17L29


Feature Type Standardized
Nominal ANOVA
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA regorafenib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA PD318088 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA ML083 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Teniposide CTRPv2 pan-cancer AAC 0.015 0.7
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.018 0.7
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV